Stay informed with the latest FDA recalls and safety alerts affecting your medications and health devices. Understanding these updates ensures your health and safety by avoiding affected products.
Not all recalls are announced on FDA.gov or in the news media. Public notification is generally issued when a product that has been widely distributed or poses a serious health hazard is recalled. However, if a company does not issue public notification of a recall, FDA may do so if the agency determines it is necessary to protect patients and consumers. Patients and consumers also may learn that their medicine has been recalled through notification from the manufacturer, their doctor or pharmacist.
FDA recommends patients talk to their health care professional about the best course of action for their health if they have a medication that has been recalled.
All information regarding FDA recalls can be found here:
FDA.gov Drug Recall Information
The formulary is updated on a regular basis to include tier changes and utilization (UM) requirements. A formulary may change during the year if we remove drugs from our formulary, add a prior authorization requirement, add quantity limits and/or step therapy restrictions on a drug, and/or move a drug to a higher cost-sharing tier.
We must notify you at least 30 days before any of these changes become effective. At the time you request a refill, you will receive a 30-day supply of the drug.
Changes to the TRICARE formulary applicable to Martin's Point USFHP since 1/1/2026
QL = Quantity Limit | PA = Prior Authorization | ST = Step Therapy
|
|
Drug Name
|
Description of Change
|
Tier
|
Effective Date
|
Source
|
| Estring |
One ring per 90 days |
2 |
12/4/2026 |
Member Letter
Prescriber Letter
|
| Femring |
One ring per 90 days |
2 |
12/4/2026 |
Member Letter
Prescriber Letter
|
| Vraylar |
Max 30 days retail pharmacy; 90 days mail order pharmacy |
3 |
12/4/2026 |
Member Letter
Prescriber Letter
|
| Tofacitinib (Xeljanz) |
Max 30 days retail pharmacy; 90 days mail order pharmacy |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Mirabegron (Myrbetriq) |
Max 30 days retail pharmacy; 90 days mail order pharmacy |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Humalog JR |
Moves to Tier 3; Max 30 days retail pharmacy, 90 days mail order pharmacy |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Insulin Lispro |
Moves to Tier 3; Max 30 days retail pharmacy, 90 days mail order pharmacy |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Arcalyst |
Moves to Tier 3; Max 30 days retail pharmacy, 90 days mail order pharmacy |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Pradaxa (75mg, 110mg, 150mg) |
Moves to Tier 2 |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Entresto |
Moves to Tier 2 |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Novolog Vial |
Moves to Tier 2; Max 30 days retail pharmacy, 90 days mail order pharmacy |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Novolog Flexpen |
Moves to Tier 2; Max 30 days retail pharmacy, 90 days mail order pharmacy |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Conjugated Estrogens (0.3mg, 0.45mg, 0.625mg, 0.9mg, 1.25mg) |
PA added to generic; brand Premarin tablets preferred |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Vyvgart Hytrulo |
Moves to Tier 2; Max 60 days all pharmacies |
3 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Tryptyr Solution |
Max 60 vials (1 carton) per 30 days all pharmacies |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Lynkuet |
Max 60 capsules per 30 days all pharmacies |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Rhapsido |
Max 60 days all pharmacies |
3 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Ozempic Injection |
Max 30 days retail pharmacy, 90 days mail order pharmacy |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Mounjaro Injection |
Max 30 days retail pharmacy, 90 days mail order pharmacy |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Ozempic Tablets |
Max 30 days retail pharmacy, 90 days mail order pharmacy |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Icotyde |
Max 60 days all pharmacies; added to maintenance list |
3 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Anoro |
Moves to Tier 2 |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Umeclidinium-vilanterol (Anoro) |
PA added; Brand Anoro preferred |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Ranitidine Tablets (150mg, 300mg) |
PA added |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Anucort-HC Suppository |
PA added |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Bisoprolol Fumarate |
PA added |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Clemastine Tablet |
PA added |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Stelara |
Moves to Tier 3 |
2 |
12/4/2026 |
Member Letter
Prescriber Letter |
| Metoprolol 12.5mg |
PA added; Moves to Tier 2 |
1 |
12/4/2026 |
Member Letter
Prescriber Letter |